Tumor necrosis factor-α gene promoter polymorphisms in chronic schizophrenia

Biological Psychiatry

Volumn 54, Issue 11, 2003, Pages 1205-1211

  Tan, Ene Choo ^a   Chong, Siow Ann ^b   Tan, Chay Hoon ^c,d   Teo, Yik Ying ^a   Peng, Kaitian ^a   Mahendran, Rathi ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY AGENCY   (Singapore)

^b INSTITUTE OF MENTAL HEALTH   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Association study; Chinese; Cytokines; Schizophrenia; SNP; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELISM; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

EID: 0344430082     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00345-7     Document Type: Article

References (61)

1. Alonso R., Chaudieu I., Diorio J., Krishnamurthy A., Quirion R., Boksa P. Interleukin-2 modulates evoked release of dopamine in rat cultured mesencephalic cells. J Neurochem. 61:1993;1284-1290.
2. Alvarez V., Mata I.F., Gonzalez P., Lahoz C.H., Martinez C., Pena J., et al. Association between the TNF-alpha -308 A/G polymorphism and the onset age of Alzheimer disease. Am J Med Genet. 114:2002;574-577. [3H].
3. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC: American Psychiatric Association.
4. Baena A., Leung J.Y., Sullivan A.D., Landires I., Vasquez-Luna N., Quinones-Berrocal J. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun. 3:2002;482-487.
5. Boin F., Zanardini R., Pioli R., Altamura C.A., Maes M., Gennarelli M. Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry. 6:2001;79-82.
6. Bouma G., Xia B., Crusius J.B., Bioque G., Koutroubakis I., Von Blomberg B.M., et al. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol. 103:1996;391-396.
7. Braun N., Michel U., Ernst B.P., Metzner R., Bitsch A., Weber F., et al. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett. 215:1996;75-78.
8. Breder C.D., Tsujimoto M., Terano Y., Scott D.W., Saper S.B. Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system. J Comp Neurol. 337:1993;543-567.
9. Bridges S.L. Jr, Jenq G., Moran M., Kuffner T., Whitworth W.C., McNicholl J. Single-nucleotide polymorphisms in tumor necrosis factor receptor genes Definition of novel haplotypes and racial/ethnic differences . Arthritis Rheum. 46:2002;2045-2050.
10. Brinkman B.M., Zuijdeest D., Kaijzel E.L., Breedveld F.C., Verweij C.L. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm. 46:1995-1996;32-41.
11. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Wagner R.L., Yolken R.H. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun. 15:2001;411-420.
12. Carrington C.V., Kondeatis E., Ramdath D.D., Norman P.J., Vaughan R.W., Stephens H.A. A comparison of HLA-DR and -DQ allele and haplotype frequencies in Trinidadian populations of African, South Asian, and mixed ancestry. Hum Immunol. 63:2002;1045-1054.
13. Czaja A.J., Cookson S., Constantini P.K., Clare M., Undorhili J.A., Dunaldson P.T., et al. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 117:1999;645-652.
14. Delgado J.C., Baena A., Thim S., Goldfeld A.E. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis. 186:2002;1463-1468.
15. Erbagci A.B., Herken H., Koyluoglu O., Yilmaz N., Tarakcioglu M. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm. 10:2001;109-115.
16. Ganguli R., Yang Z., Shurin G., Chengappa K.N., Brar J.S., Gubbi A.V., et al. Serum interleukin-6 concentration in schizophrenia Elevation associated with duration of illness . Psychiatry Res. 51:1994;1-10.
17. Gershon E.S., Badner J.A., Goldin L.R., Sanders A.R., Cravchik A., Detera-Wadleigh S.D. Closing in on genes for manic-depressive illness and schizophrenia. Neuropsychopharmacology. 18:1998;233-242.
18. Haack M., Hinze-Selch D., Fenzel T., Kraus T., Kuhn M., Schuld A., et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission Effects of confounding factors and diagnosis . J Psychiatr Res. 33:1999;407-418.
19. Hajeer A.H., Hutchinson I.V. Influence of TNF-alpha gene polymorphisms on TNF-alpha production and disease. Hum Immunol. 62:2001;1191-1199.
20. Katila H., Appelberg B., Hurme M., Rimon R. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res. 121:1994;29-34.
21. Killestein J., Kalkers N.F., Meilof J.F., Barkhof F., van Lier R.A., Polman C.H. TNF-alpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS. Neurology. 57:2001;1129-1131.
22. Knight J.C., Udalova J., Hill A.V., Greenwood B.M., Peshu N., Marah K., et al. A polymorphism that affects OGT-1 binding to the TNF promolar region is associated with severe malaria. Nat Genet. 22:1999;145-150.
23. Kowalski J., Blada P., Kucia K., Madej A., Herman Z.S. Neuroleptics normalize increased release of interleukin-1β and tumor necrosis factor-α from monocytes in schizophrenia. Schizophr Res. 50:2001;169-175.
24. Kroeger K.M., Carville K.S., Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 34:1997;. 391-309.
25. Lamsis F., Flannery G.R., White N.G., Muratore R., Kaelan C., Mitchell R.J. Alleles and haplotypes of tumor necrosis factor (TNF) alpha and beta genes in three ethnic populations of Sulawesi Indonesia. Hum Biol. 74:2002;381-396.
26. Lazarus R., Klimecki W.T., Palmer L.J., Kwiatkowski D.J., Silverman E.K., Brown A. Single-nucleotide polymorphisms in the interleukin-10 gene Differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups . Genomics. 80:2002;223-228.
27. Lewontin T.C. The interaction of selection and linkage. I. General considerations, heterotic models. Genetics. 49:1964;49-67.
28. Li Kam Wa T.C., Mansur A.H., Britton J., Williams G., Pavord J., Richards K., et al. Association between -308 tumor necrosis factor promoter polymorphism and bronchial hyperactivity in asthma. Clin Exp Allergy. 29:1999;1204-1208.
29. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 33:2003;177-182.
30. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 113:1998;401-406.
31. Maes M., Meltzer H.Y., Bosmans E. Immune-inflammatory markers in schizophrenia Comparison to normal controls and effects of clozapine . Acta Psychiatr Scand. 89:1994;346-351.
32. Merill J.E. Tumor necrosis factor alpha, interleukin-1 and related cytokines in brain development Normal and pathological . Dev Neurosci. 14:1992;1-10.
33. Mira J.P., Cariou A., Grall F., Delelaux C., Loaser M.R., Hashmati F., et al. Association of TNF2, a TNF-alpha promoter polymorphism with septic shock susceptibility and mortality A multicenter study . JAMA. 282:1999;561-568.
34. Monteleone P., Fabrazzo M., Tortorella A., Maj M. Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia Effects of clozapine treatment . Psychiatry Res. 71:1997;11-17.
35. Muller N., Riedel M., Gruber R., Ackenheil M., Schwarz M.J. The immune system and schizophrenia. An integrative view. Ann N Y Acad Sci. 917:2000;456-467.
36. Nagatsu T., Mogi M., Ichinose H., Togari A. Cytokines in Parkinson's disease. J Neural Transm Suppl. 58:2000;143-151.
37. Niizeki H., Naruse T., Hecker K.H., Taylor J.R., Kurimoto I., Shimizu T. Polymorphisms in the tumor necrosis factor (TNF) genes are associated with susceptibility to effects of ultraviolet-B radiation on induction of contact hypersensitivity. Tissue Antigens. 58:2001;369-378.
38. Patterson P.H. Maternal infection Window on neuroimmune interactions in fetal brain development and mental illness . Curr Opin Neurobiol. 12:2002;115-118.
39. Plata-Salaman C., Turrin N. Cytokine interactions and cytokine balance in the brain Relevance to neurology and psychiatry . Mol Psychiatry. 4:1999;302-306.
40. Pollmacher T., Hinze-Selch D., Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol. 5:1996;403-409.
41. Riedel M., Kronig H., Schwarz M.J., Engel R.R., Kuhn K.U., Sikorski C., et al. No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia. Eur Arch Psychiatry Clin Neurosci. 252:2002;232-234.
42. Rood M.J., van Krugton M.V., Zanelli E., van der Lindon M.W., Kaijsors V., Schreuder G.M., et al. TNF -308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 43:2000;129-134.
43. Schwab S.G., Hallmayer J., Albus M., Lerer B., Eckstein G.N., Borrmann M., et al. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings Support for loci on chromosome 10p and 6 . Mol Psychiatry. 5:2000;638-649.
44. Shohami E., Ginis I., Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 10:1999;119-130.
45. Skoog T., van't Hooft F.M., Kallin B., Jovinge S., Boquist S., Nilsson J., et al. A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 8:1999;1443-1449.
46. Smith R.S. Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes? Med Hypotheses. 34:1991;225-229.
47. Smith R.S. A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med Hypotheses. 39:1992;248-257.
48. Smith R.S., Maes M. The macrophage-T-lymphocyte theory of schizophrenia Additional evidence . Med Hypotheses. 45:1995;135-141.
49. Soliven B., Albert J. Tumor necrosis factor modulates the inactivation of catecholamine secretion in cultured sympathetic neurons. J Neurochem. 58:1992;1073-1078.
50. Straub R.E., MacLean C.J., Kendler K.S. The putative schizophrenia locus on chromosome 6p A brief overview of the linkage studies . Mol Psychiatry. 1:1996;89-92.
51. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiatry. 7:2002;542-559.
52. Theodoropoulou S., Spanakos G., Baxevanis C.N., Economou M., Gritzapis A.D., Papamichail M.P., et al. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophr Res. 47:2001;13-25.
53. Tokunaga K., Ohashi J., Bannai M., Juji T. Genetic link between Asians and native Americans Evidence from HLA genes and haplotypes . Hum Immunol. 62:2001;1001-1008.
54. Turecki G., Rouleau G.A., Joober R., Mari J., Morgan K. Schizophrenia and chromosome 6p. Am J Med Genet. 74:1997;195-198.
55. Ubalee R., Suzuki F., Kikuchi M., Tasanor O., Wattanagoon Y., Ruangweerayut R. Strong association of a tumor necrosis factor-alpha promoter allele with cerebral malaria in Myanmar. Tissue Antigens. 58:2001;407-410.
56. van Heel D.A., Udalova I.A., De Silva A.P., McGovern D.P., Kinouchi Y., Hull J., et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors. Hum Mol Genet. 11:2002;1281-1289.
57. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 94:1997;3195-3199.
58. Wright P., Donaldson P.T., Underhill J.A., Choudhuri K., Doherty D.G., Murray R.M. Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am J Psychiatry. 153:1996;1530-1533.
59. Wu W.S., McClain K.L. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res. 17:1997;631-635.
60. Yolken R.H., Karlsson H., Yee F., Johnston-Wilson N.L., Torrey E.F. Endogenous retroviruses and schizophrenia. Brain Res Brain Res Rev. 31:2000;193-199.
61. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., et al. Cytokine-specific central monamine alternative induced by interleukin-1, -2 and -6. Brain Res. 643:1994;40-49.